Analyze Diet
Equine veterinary journal2022; doi: 10.1111/evj.13852

Conditioned serum in vitro treatment of chondrocyte pellets and osteoarthritic explants.

Abstract: Autologous conditioned serum (ACS) is used to treat osteoarthritis in horses, although its effects are not fully investigated. Objective: To investigate the effects of equine serum and conditioned serum on chondrocytes stimulated with interleukin (IL)-1β and cartilage explants with mild osteoarthritis. Methods: In vitro experimental study. Methods: The effect of three different serum preparations (unincubated control [PS], serum incubated 24 h [PS24h], and serum incubated 24 h in ACS containers [PCS]) pooled from lame horses were tested in two in vitro models. IL-1β and IL-1 receptor antagonist (IL-1Ra) concentrations were measured in all sera. In model 1, chondrocyte pellet cultures were stimulated with IL-1β prior to treatment with the serum preparations for 2 and 48 h. Microarray, polymerase chain reaction, and matrix metallopeptidase-13 analyses were performed. In model 2, cartilage explants from horses with structural osteoarthritis were treated with PS or PCS on days 0, 6, and 12, or left untreated, and evaluated at day 24 using the OARSI grading scale for histological evaluation of articular cartilage. Results: The IL-1Ra concentration in PS24h and PCS was significantly higher than in PS. In model 1, inflammation- and cartilage matrix degradation-related genes were upregulated after 48 h in all treatment groups versus untreated controls. Cartilage matrix molecules, aggrecan and collagens, were downregulated in PS24h- and PCS- treated pellets versus untreated controls. Growth factor signalling genes were upregulated-FGF7 in all treatment groups, BMP2 in PS24h-, and INHBA in PCS-treated- compared with untreated controls. In model 2, the OARSI score at day 24 was not significantly different between treatment groups. Conclusions: Results from in vitro models cannot be directly translated to in vivo situations. Conclusions: In vitro treatment with conditioned serum did not alleviate IL-1β-induced responses in chondrocyte pellets or lead to morphological improvement in osteoarthritic cartilage explants.
Publication Date: 2022-04-29 PubMed ID: 35485784DOI: 10.1111/evj.13852Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research examined the effects of autologous conditioned serum (ACS), a treatment used for osteoarthritis in horses, on chondrocytes cells and osteoarthritic cartilage. The study found that while the serum influenced some gene expressions in cultured cells, it did not necessarily improve osteoarthritic conditions in vitro (in lab setting).

Research Methods

  • The research employed in vitro experimental models. Specifically, three different serum preparations (PS, PS24h, and PCS) pooled from lame horses were tested.
  • Two models were used. The first involved chondrocyte pellet cultures stimulated with the protein IL-1β then treated with the serums for 2 and 48 hours. In the second model, cartilage sections with mild osteoarthritis were treated at set intervals with PS or PCS serum, or left untreated.
  • Concentrations of IL-1β and IL-1 receptor antagonist (IL-1Ra) were measured in all the tested serums. Furthermore, microarray, PCR, and matrix metallopeptidase-13 analyses were performed to assess gene expression and cartilage degradation.

Research Findings

  • It was found that the concentration of IL-1Ra, a protein that inhibits the activities of IL-1β, was significantly higher in PS24h and PCS serums than in the control PS serum.
  • Results showed upregulation of inflammation and cartilage matrix degradation-related genes in all treatment groups compared to the untreated controls. On the other hand, cartilage matrix molecules – aggrecan and collagens – were downregulated in the PS24h- and PCS- treated cells compared to untreated controls.
  • Some growth factor signaling genes such as FGF7, BMP2, and INHBA were upregulated in the treatment groups compared to the controls.
  • In the osteoarthritis model, the OARSI score, a grading scale for the histological evaluation of articular cartilage, showed no significant difference between treatment groups at the end of the study.

Conclusions

  • The research underscored that results obtained from in vitro models might not directly translate to in vivo situations (within living organisms).
  • The study concluded that in vitro treatment with conditioned serum did not reduce IL-1β-induced responses in chondrocyte pellets or morphologically improve osteoarthritic cartilage explants.

Cite This Article

APA
Löfgren M, Ekman S, Ekholm J, Engström M, Fjordbakk CT, Svala E, Holm Forsström K, Lindahl A, Skiöldebrand E. (2022). Conditioned serum in vitro treatment of chondrocyte pellets and osteoarthritic explants. Equine Vet J. https://doi.org/10.1111/evj.13852

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English

Researcher Affiliations

Löfgren, Maria
  • Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Ekman, Stina
  • Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Ekholm, Josefine
  • Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska University Hospital, Gothenburg University, Gothenburg, Sweden.
Engström, Mona
  • Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska University Hospital, Gothenburg University, Gothenburg, Sweden.
Fjordbakk, Cathrine T
  • Department of Companion Animal Clinical Sciences, Faculty of Veterinary Medicine, Norwegian University of Life Sciences, Oslo, Norway.
Svala, Emilia
  • Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden.
  • Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska University Hospital, Gothenburg University, Gothenburg, Sweden.
Holm Forsström, Karin
  • Equine Clinic, University Animal Hospital, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Lindahl, Anders
  • Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska University Hospital, Gothenburg University, Gothenburg, Sweden.
Skiöldebrand, Eva
  • Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden.
  • Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska University Hospital, Gothenburg University, Gothenburg, Sweden.

Citations

This article has been cited 1 times.
  1. Fan M, Zhang J, Zhou L, Chen Z, Bao R, Zheng L, Tong P, Ma Y, Shan L. Intra-articular injection of placental mesenchymal stromal cells ameliorates pain and cartilage anabolism/catabolism in knee osteoarthritis. Front Pharmacol 2022;13:983850.
    doi: 10.3389/fphar.2022.983850pubmed: 36523496google scholar: lookup